Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck KGaA
Biotech
Merck KGaA picks new pilot for turbulent times—Chutes & Ladders
Merck KGaA picks new pilot for turbulent times. Former state official boards Flagship. ADC outfit Myricx makes CEO selection.
Darren Incorvaia
Sep 26, 2025 8:30am
Merck KGaA lands new R&D chief—Chutes & Ladders
Sep 5, 2025 8:30am
Merck KGaA swoops to $2B neurological disease pact with Skyhawk
Aug 18, 2025 9:49am
Merck KGaA sheds light on failed portion of phase 2 lupus trial
Jun 12, 2025 9:41am
Protara gears up for next commercial steps—Chutes & Ladders
Jun 6, 2025 8:30am
Merck KGaA posts tumor data ahead of showdown with Daiichi, Ono
May 28, 2025 8:45am
